Pacira Biosciences, Stock Current Valuation
| PCRX Stock | USD 17.55 0.17 0.98% |
Valuation analysis of Pacira BioSciences, helps investors to measure Pacira BioSciences,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to rise to about 1.8 B in 2024, whereas Enterprise Value Over EBITDA is likely to drop 11.62 in 2024. Fundamental drivers impacting Pacira BioSciences,'s valuation include:
Price Book 1.0811 | Enterprise Value 1 B | Enterprise Value Ebitda 29.948 | Price Sales 1.166 | Forward PE 5.1177 |
Undervalued
Today
Please note that Pacira BioSciences,'s price fluctuation is very steady at this time. Calculation of the real value of Pacira BioSciences, is based on 3 months time horizon. Increasing Pacira BioSciences,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Pacira BioSciences, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pacira Stock. However, Pacira BioSciences,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.55 | Real 26.64 | Target 55.1 | Hype 17.44 | Naive 17.6 |
The intrinsic value of Pacira BioSciences,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pacira BioSciences,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pacira BioSciences, helps investors to forecast how Pacira stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pacira BioSciences, more accurately as focusing exclusively on Pacira BioSciences,'s fundamentals will not take into account other important factors: Pacira BioSciences, Company Current Valuation Analysis
Pacira BioSciences,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Pacira BioSciences, Current Valuation | 1 B |
Most of Pacira BioSciences,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pacira BioSciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pacira Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Pacira BioSciences, is extremely important. It helps to project a fair market value of Pacira Stock properly, considering its historical fundamentals such as Current Valuation. Since Pacira BioSciences,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pacira BioSciences,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pacira BioSciences,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Pacira BioSciences, has a Current Valuation of 1 B. This is 93.03% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 93.98% higher than that of the company.
Pacira Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pacira BioSciences,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pacira BioSciences, could also be used in its relative valuation, which is a method of valuing Pacira BioSciences, by comparing valuation metrics of similar companies.Pacira BioSciences, is currently under evaluation in current valuation category among its peers.
Pacira BioSciences, ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pacira BioSciences,'s sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pacira BioSciences,'s managers, analysts, and investors.Environmental | Governance | Social |
Pacira Fundamentals
| Return On Equity | -0.11 | ||||
| Return On Asset | 0.0417 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 1 B | ||||
| Shares Outstanding | 46.17 M | ||||
| Shares Owned By Insiders | 2.10 % | ||||
| Shares Owned By Institutions | 97.90 % | ||||
| Number Of Shares Shorted | 5.46 M | ||||
| Price To Earning | 14.34 X | ||||
| Price To Book | 1.08 X | ||||
| Price To Sales | 1.17 X | ||||
| Revenue | 674.98 M | ||||
| Gross Profit | 393.23 M | ||||
| EBITDA | 162.9 M | ||||
| Net Income | 41.95 M | ||||
| Cash And Equivalents | 316.39 M | ||||
| Cash Per Share | 6.90 X | ||||
| Total Debt | 586.04 M | ||||
| Debt To Equity | 1.10 % | ||||
| Current Ratio | 3.95 X | ||||
| Book Value Per Share | 16.24 X | ||||
| Cash Flow From Operations | 154.65 M | ||||
| Short Ratio | 9.34 X | ||||
| Earnings Per Share | (1.98) X | ||||
| Price To Earnings To Growth | (3.83) X | ||||
| Target Price | 18.0 | ||||
| Number Of Employees | 711 | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 810.34 M | ||||
| Total Asset | 1.57 B | ||||
| Retained Earnings | (106.8 M) | ||||
| Working Capital | 412.61 M | ||||
| Current Asset | 252.58 M | ||||
| Current Liabilities | 149.79 M | ||||
| Net Asset | 1.57 B |
About Pacira BioSciences, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pacira BioSciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pacira BioSciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pacira BioSciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.